PDF Publication Title:
Text from PDF Page: 009
www.nature.com/scientificreports/ 21. Ansari, M. A., Khan, H. M., Khan, A. A., Cameotra, S. S. & Alzohairy, M. A. Anti-biofilm efficacy of silver nanoparticles against MRSA and MRSE isolated from wounds in a tertiary care hospital. Indian. J. Med. Microbiol. 33, 101–109 (2015). 22. Vasanth, K., Ilango, K., Mohan K. R., Agrawal, A. & Dubey, G. P. Anticancer activity of Moringa oleifera mediated silver nanoparticles on human cervical carcinoma cells by apoptosis induction. Colloids Surf. B. Biointerfaces. 1, 354–359 (2014). 23. Kora, A. J. & Sashidhar, R. B. Antibacterial activity of biogenic silver nanoparticles synthesized with gum ghatti and gum olibanum: a comparative study. J. Antibiot. 68, 88–97 (2015). 24. Wong, M. S. et al. Antibacterial property of Ag nanoparticle-impregnated N-doped titania films under visible light. Sci. Rep. doi: 10.1038/srep11978. 2015. 25. Lemire, J. A., Harrison, J. J. & Turner, R. J. Antimicrobial activity of metals: mechanisms, molecular targets and applications. Nat. Rev. Microbiol. 11, 371–384 (2013). 26. David, L. et al. Green synthesis, characterization and anti-inflammatory activity of silver nanoparticles using European black elderberry fruits extract. Colloids Surf. B. Biointerfaces 122, 767–777 (2014). 27. El-Rafie, H. M. & Hamed, M. A. Antioxidant and anti-inflammatory activities of silver nanoparticles biosynthesized from aqueous leaves extracts of four Terminalia species. Adv. Nat. Sci: Nanosci. Nanotechnol. doi: 10.1088/2043-6262/5/3/035008 (2014). 28. Castillo, P. M. et al. Tiopronin monolayer-protected silver nanoparticles modulate IL-6 secretion mediated by Toll-like receptor ligands. Nanomedicine (Lond). 5, 627–35 (2008). 29. Ashraf, J. M. et al. Physicochemical analysis of structural alteration and AGEs generation during glycation of H2A histone by 3-Deoxyglucosone. IUBMB Life 66, 686–693 (2014). 30. Medda, S., Hajra, A., Dey, U., Bose, P. & Mondal, N. K. Biosynthesis of silver nanoparticles from Aloe vera leaf extract and antifungal activity against Rhizopus sp. and Aspergillus sp. Appl. Nanosci. doi: 10.1007/s13204-014-0387-1 31. Ansari, M. A. et al. Green synthesis of Al2O3 nanoparticles and their bactericidal potential against clinical isolates of multi-drug resistant Pseudomonas aeruginosa. World J. Microbiol. Biotechnol. 31, 153–64 (2015). 32. Udenfriend, S. et al. Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science 178, 871–872 (1972). 33. Smith, R. E. & MacQuarrie, R. A sensitive fluorometric method for the determination of arginine using 9,10-phenanthrenequinone. Anal. Biochem. 90, 246–255 (1978). 34. Levine, R. L., Williams, J. A., Stadtman, E. R. & Shacter, E. Carbonyl assays for determination of oxidatively modified proteins. Meth. Enzymol. 233, 346–357 (1994). 35. Misselwitz, J., Franke, S., Kauf, E., John, U. & Stein, G. Advanced glycation end products in children with chronic renal failure and type 1 diabetes. Pediatr. Nephrol. 17, 316–321 (2002). 36. Rabbani, G., Ahmad, E., Zaidi, N., Fatima, S. & Khan, R. H. pH-Induced molten globule state of Rhizopus niveus lipase is more resistant against thermal and chemical denaturation than its native state. Cell. Biochem. Biophys. 62, 487–499 (2012). 37. Li. S. et al. Green synthesis of silver nanoparticles using Capsicum annuum L. extract. Green. Chem. 9, 852–858 (2007). 38. Sastry, M., Mayya, K. S. & Bandyopadhyay, K. pH Dependent changes in the optical properties of carboxylic acid derivatized silver colloidal particles. Colloids Surf. A: Physicochem. & Engi. Aspects 127, 221–228 (1997). 39. Ulrich, P. & Cerami, A. Protein glycation, diabetes, and aging. Recent Prog. Horm. Res. 56, 1–21 (2001). 40. Thornalley, P. J. The glyoxalase system in health and disease. Mol. Aspects Med. 14, 287–372 (1993). 41. Reynolds, T. M. Chemistry of nonenzymic browning. I. The reaction between aldoses and amines. Adv. Food Res. 12, 1–52 (1963). 42. Cerami, C. et al. Tobacco smoke is a source of toxic reactive glycation products. Proc. Natl. Acad. Sci. USA 94, 3915–13920 (1997). 43. Bolton, W. K. et al. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am. J. Nephrol. 24, 32–40 (2004). 44. Brownlee, M. The pathological implications of protein glycation. Clin. Invest. Med. 18, 275–281 (1995). 45. Schmitt, A., Gasic-Milenkovic, J. & Schmitt, J. Characterization of advanced glycation end products: mass changes in correlation to side chain modifications. Anal. Biochemi. 346, 101–106 (2005). 46. Sell, D. R. & Monnier, V. M. Structure elucidation of a senescence cross-link from human extracellular matrix. J. Biol. Chem. 264, 21597–21602 (1989). 47. Ahmed, M. U., Thorpe, S. R. & Baynes, J. W. Identification of Nε-(carboxymethyl)lysine as a degradation product of fructose lysine in glycated protein. J. Biol. Chem. 261, 4889–4894 (1986). 48. Wells-Knecht, K. J. et al. New biomarkers of Maillard reaction damage to proteins. Nephrol. Dial. Transplant. 11, 41–47 (1996). 49. Kessel, L., Kalinin, S., Nagaraj, R. H., Larsen, M. & Johansson, L. B. Time-resolved and steady-state fluorescence spectroscopic studies of the human lens with comparison to argpyrimidine, pentosidine and 3-OH-kynurenine. Photochem. Photobiol. 76, 549–554 (2002). 50. Degenhardt, T. P., Thorpe, J. S. & Baynes, R. W. Chemical modification of proteins by methylglyoxal. Cell. Mol. Biol. (Noisyle Grand) 44, 1139–1145 (1998). 51. Obayashi, H. et al. Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo. Biochem. Biophys. Res. Commun. 226, 37–41 (1996). 52. Hori, M. et al. Experimental models for advanced glycation end product formation using albumin, collagen, elastin, keratin and proteoglycan. Anti-Aging Med. 9, 125–134 (2012). 53. Bhattacharya, J., Jasrapuria, S., Sarkar, T., GhoshMoulick, R. & Dasgupta, A. K. Gold nanoparticle based tool to study protein conformational variants: implications in hemoglobinopathy. Nanomedicine 3, 14–19 (2007). 54. Singha, S., Bhattacharya, J., Datta, H. & Dasgupta, A. K. Anti-glycation activity of gold nanoparticles. Nanomedicine: Nanotechno. Bio. Medi. 5, 21–29 (2009). 55. Sheikpranbabu, S. et al. The inhibition of advanced glycation end-products-induced retinal vascular permeability by silver nanoparticles. Biomaterials 31, 2260–2271 (2010). 56. Harmsen, B. J. & Braam, W. G. On the conformation of bovine serum albumin after alkaline or thermal denaturation. Int. J. Pro. Res. 1, 225–33 (1969). 57. Zheng, N. et al. Characterization of protein in old myocardial infarction by FTIR micro-spectroscopy. J. Huazhong Univ. Sci. Technol. 30, 546–550 (2010). 58. Khatoon, F., Moinuddin, Alam, K. & Ali, A. Physicochemical and immunological studies on 4-hydroxynonenal modified HSA: Implications of protein damage by lipid peroxidation products in the etiopathogenesis of SLE. Hum. Immunol. 73, 1132–1139 (2012). 59. Sastry, M., Kumar, A., Datar, S., Dharmadhikari, C. V. & Ganesh, K. N. DNA mediated electrostatic assembly of gold nanoparticles into linear arrays by a simple drop-coating procedure. Appl. Phys. Lett. 78, 2943 (2001). 60. Hu,X.,Cheng,W.,Wang,T.,Wang,E.&Dong,S.Well-orderedend-to-endlinkageofgoldnanorods.Nanotechnology16,2164–2169 (2005). 61. Ahmed, M., AlSalhi, M. S. & Siddiqui, M. K. J. Silver nanoparticle applications and human health. Clin. Chim. Acta. 411, 1841–1848 (2010). Scientific RepoRts | 6:20414 | DOI: 10.1038/srep20414 9PDF Image | Green synthesis of silver nanoparticles inhibitory effects on AGEs
PDF Search Title:
Green synthesis of silver nanoparticles inhibitory effects on AGEsOriginal File Name Searched:
srep20414.pdfDIY PDF Search: Google It | Yahoo | Bing
Turbine and System Plans CAD CAM: Special for this month, any plans are $10,000 for complete Cad/Cam blueprints. License is for one build. Try before you buy a production license. More Info
Waste Heat Power Technology: Organic Rankine Cycle uses waste heat to make electricity, shaft horsepower and cooling. More Info
All Turbine and System Products: Infinity Turbine ORD systems, turbine generator sets, build plans and more to use your waste heat from 30C to 100C. More Info
CO2 Phase Change Demonstrator: CO2 goes supercritical at 30 C. This is a experimental platform which you can use to demonstrate phase change with low heat. Includes integration area for small CO2 turbine, static generator, and more. This can also be used for a GTL Gas to Liquids experimental platform. More Info
Introducing the Infinity Turbine Products Infinity Turbine develops and builds systems for making power from waste heat. It also is working on innovative strategies for storing, making, and deploying energy. More Info
Need Strategy? Use our Consulting and analyst services Infinity Turbine LLC is pleased to announce its consulting and analyst services. We have worked in the renewable energy industry as a researcher, developing sales and markets, along with may inventions and innovations. More Info
Made in USA with Global Energy Millennial Web Engine These pages were made with the Global Energy Web PDF Engine using Filemaker (Claris) software.
Infinity Turbine Developing Spinning Disc Reactor SDR or Spinning Disc Reactors reduce processing time for liquid production of Silver Nanoparticles.
| CONTACT TEL: 608-238-6001 Email: greg@infinityturbine.com | RSS | AMP |